期刊文献+

微载体培养人肝细胞系作为人工肝生物材料的研究 被引量:2

Cultivation of a human liver cell line with microcarriers acting as the biological material of artificial liver
原文传递
导出
摘要 目的 为提高人肝细胞系的培养效率和细胞获取数量。方法 本研究采用微载体细胞培养技术进行了人肝细胞系CL-1的高密度培养,动态观察细胞生长,检测肝细胞特异性功能变化。结果 CL-1在微载体Cytodex-3上生长良好,于培养的第7天达到高峰,细胞数量为2.13×10^8/100ml,白蛋白合成量71.23μg/100ml.尿素合成量23.32mg/100ml,安定转化量619.7μg/100ml,与CL-1普通培养结果比较,细胞产量是普通培养的49.3倍.而白蛋白合成量、尿素合成量及安定转化量则分别是普通培养的39.8倍、41.6倍和33.3倍。结论 微载体培养CL-1可提高培养效率和细胞数量.且具有较好的功能,微载体高密度培养CL-1可作为组合型人工肝的生物材料。 Objective To raise the cultivation efficiency and yield of human liver cell line CL-1. Methods High density cultivation of CL-1 on microcarriers was carried out with periodic observation of their growth and proliferation.The specific functions of human liver cell were also determined.Results Cells of CL-1 cell line grew well on microcarrier Cytodex-3 and on the 7th day the peak was reached. The amount of CL-1 ceils was 2.13×10~8 and the total amount of albumin synthesis reached 71.23μg, urea synthesis 23.32mg and diazepam transformation 619.7μg respectively.The yield of C1-1 on micro- carriers was 49.3 times over that of conventional cultivation.The amounts of albumin synthesis,urea synthesis and diazepam transformation were 39.8 times,41.6 times and 33.3 times over those of con- ventional cultivation,respectively.Conclusions The human liver cell line CL-1 can be cultivated to a high density with Cytodex-3 and has better biological functions.High density cultivation of CL-1 on mi- crocarriers can act as the biological material of artificial liver.
出处 《中华肝胆外科杂志》 CAS CSCD 1998年第4期222-225,共4页 Chinese Journal of Hepatobiliary Surgery
基金 国家自然科学基金资助项目(编号39570212)
关键词 人肝细胞系 微载体 人工肝 生物材料 白蛋白 安定 高密度培养 细胞数量 体高 转化 Artificial liver,biological Human liver cell line Microcarrier
  • 相关文献

参考文献1

二级参考文献1

  • 1A. P. Li,Susan M. Colburn,Dale J. Beck. A simplified method for the culturing of primary adult rat and human hepatocytes as multicellular spheroids[J] 1992,In Vitro Cellular & Developmental Biology - Animal(9-10):673~677

共引文献4

同被引文献16

  • 1李铎,孙家邦.生物人工肝[J].中华外科杂志,1996,34(9):540-542. 被引量:7
  • 2DIXIT V. Development of a bioartificial liver using isolated hepatocytes[J]. Artif Organs, 1994, 18(4): 371.
  • 3WERNER A, DUVAR S, MUTHING J, et al. Cultivation of immortalized human hepatocytes HepZ on macroporous CultiSpher G microcarriers[J]. Biotechnol Bioeng, 2000, 68(1): 59.
  • 4ANAND AC, BHONDE RR, KURUP S, et al. Bio-artificial liver from cultured human foetal hepatocytes: feasibility and prospects[J]. Trop Gastroenterol, 2000, 21(1):22.
  • 5YOON JH, LEE HV, LEE JS, et al. Development of a non-transformed human liver cell line with differentiated-hepatocyte and urea-synthetic functions: applicable for bioartificial liver[J]. Int J Artif Organs, 1999, 22(11): 769.
  • 6SEANC, CARLOS O. Esquivel and Emmet B. Keeffe. New approaches to supporting the falling liver[J]. Annu rev Medicine, 1998, 49(1): 85.
  • 7WANG L, SUN J, WANG C, et al. Analysis of multivariables during porcine liver digestion to improve hepatocyte yield and viability for use in bioartificial liver support systems[J]. Cell Transplant 2000, 9(3):329.
  • 8IJIMA H, NAKAZAWA K, KOYAMA S, et al. Conditions required for a hybrid artificial liver support system using a PUF/hepatocyte-spheroid packed-bed module and it's use in dogs with liver failure[J]. Int J Artif Organs, 2000, 23(7): 446.
  • 9KAMOHARA Y, FUJIOKA H, EGUCHI S, et al. Comparative study of bioartificial liver support and plasma exchange for treatment of pigs with fulminant hepatic failure[J]. Artif Organs, 2000, 24(4): 265.
  • 10CUERVAS-MONS V, COLAS A, RIVERA JA, et al. In vivo efficacy of a bioartificial liver in improving spontaneous recovery from fulminant hepatic failure: a controlled study in pigs[J]. Transplantation, 2000 15, 69(3): 337.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部